首页> 外文期刊>Progress in Artificial Intelligence >A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics
【24h】

A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics

机译:降低充血性心力衰竭中的再入院率的新策略:间歇性经验静脉利尿剂

获取原文
获取原文并翻译 | 示例
           

摘要

Improvements in the medical management of heart failure have changed the course of the disease. However, mortality rates, hospitalization rates, and treatment costs are not at desired levels. Diuretics have been widely used in the treatment of congestion in heart failure patients. The following case reports represent a special patient group treated and followed by cardiology clinic. Treatment approach of each case report has been tailored on an individual basis depending on the clinical course and hospitalization rates of patients. Authors have highlighted and discussed the common aspects and future perspectives of their cases in which post-discharge intermittent empirical intravenous diuretic administration dramatically improved the clinical status and readmission number due to decompensated congestive heart failure. This is a relatively new and promising approach, which has been thought to cease the recycle of diuretic resistance and silent increase of fluid congestion in patients with congestive heart failure and frequent hospitalization. Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved.
机译:心力衰竭的医学管理的改善已经改变了疾病的过程。但是,死亡率,住院费率和治疗费用不受所需的水平。利尿剂已被广泛用于治疗心力衰竭患者的拥堵。以下案例报告代表了一个特殊的患者组治疗和后面的心脏病诊所。根据患者的临床课程和住院率,每种案例报告的治疗方法已根据患者的临床课程和住院费率量身定制。作者突出显示并讨论了其案例的共同方面和未来的观点,其中出院后间歇性经验静脉注射利尿剂给药由于代错的充血性心力衰竭而显着改善了临床状态和入院数量。这是一种相对较新和有希望的方法,已经被认为停止患有充血性心力衰竭和频繁住院患者的利尿抗性和沉默的流体充血。版权所有(c)2020 Wolters Kluwer Health,Inc。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号